...
首页> 外文期刊>Addictive behaviors >Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): Implications for risk reduction
【24h】

Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): Implications for risk reduction

机译:非洲裔美国人的非医疗处方药用途(eCstasy / molly):对风险减少的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Recent data suggest that both nonmedical prescription drug and MDMA (ecstasy/molly) use have risen among African Americans. However, studies investigating these two forms of drug use among African Americans are rare. As a result, very little is known about African-American MDMA users and their nonmedical use of prescription medications. The primary goal of this study, therefore, was to describe patterns of nonmedical prescription drug use among African Americans who use MDMA. We also assessed alcohol and illicit drug use among the sample. Surveys (n = 100) and in-depth interviews (n = 15) were conducted with African-American young adults in Southwest Florida between August 2014 and November 2015. Survey results show that a significant proportion of the sample used MDMA in conjunction with prescription medications (benzodiazepines = 59%; opioids = 35%; stimulants = 13%). Qualitative findings suggest that benzodiazepine medications were used to alleviate MDMA comedown symptoms, opioids were used to achieve a different quality high, and stimulants were used to provide added energy throughout the night. These results suggest that treatment practitioners and harm reduction professionals should pay particular attention to informing users of the potential hazards of combining MDMA with prescription medications. Although additional research is clearly needed, these findings are an important first step towards understanding both nonmedical prescription drug and MDMA use among African Americans, and could be used to tailor treatment and risk reduction interventions to this population.
机译:最近的数据表明,非洲裔美国人的非医疗处方药和MDMA(Ecstasy / Molly)使用中升起。然而,研究在非洲裔美国人中调查这两种形式的药物使用的研究很少见。因此,关于非洲裔美国MDMA用户的知识和不适用于处方药物的非医疗用途很少。因此,本研究的主要目标是描述使用MDMA的非裔美国人之间的非医疗处方药的模式。我们还评估了样品中的酒精和非法药物使用。 2014年8月和2015年11月在佛罗里达州西南部的非洲裔美国人年轻人进行了调查(n = 100)和深入访谈药物(苯并二氮卓蛋白= 59%;阿片类药物= 35%;兴奋剂= 13%)。定性发现表明,苯二氮卓药用来缓解MDMA症状,阿片类药物用于达到不同的质量高,并且兴奋剂用于全夜提供增加的能量。这些结果表明,治疗从业者和伤害减少专业人员应特别注意向用户通知用户将MDMA与处方药中的潜在危害。虽然清楚地需要额外的研究,但这些发现是了解非洲裔美国人之间非医疗处方药和MDMA使用的重要阶段,并且可用于量身定制对该人口的处理和减少干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号